Bitijen to Participate in BIX 2026, "Highlighting CMO Capabilities"

Seeking New Business Opportunities

Bitijen said on October 21 that it will participate in BioPlus-Interphex Korea 2026 (BIX 2026), which will be held from October 28 to 30 at COEX in Gangnam-gu, Seoul.

Bitijen has participated in BIX for four consecutive years since 2023, continuing its business networking with domestic and international pharmaceutical companies. This year, it plans to set up a dedicated meeting space within its independent booth to hold partnering meetings with potential clients and identify new business opportunities.

Bitigen will participate in BioPlus-Interphex Korea 2026 (BIX 2026), taking place from the 28th to the 30th at COEX in Gangnam-gu, Seoul. Bitigen

At the exhibition, Bitijen plans to highlight its contract manufacturing organization (CMO) capabilities, spanning drug substances (DS) through finished drug products (DP), including prefilled syringes (PFS), with a focus on its quality competitiveness and plans to expand production facilities.

Bitijen has secured a total of 17 cGMP certifications associated with global regulatory agencies, including the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and Japan's Pharmaceuticals and Medical Devices Agency (PMDA).

A Bitijen representative said, "We will expand opportunities to collaborate with potential clients at home and abroad and continue to strengthen our competitiveness in the global CMO market."

This content was produced with the assistance of AI translation services.